Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $1.31 Million - $1.6 Million
-30,040 Reduced 5.9%
479,080 $21 Million
Q2 2022

Aug 02, 2022

SELL
$46.53 - $55.17 $2.7 Million - $3.2 Million
-57,980 Reduced 10.22%
509,120 $26.7 Million
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $2.06 Million - $2.55 Million
45,040 Added 8.63%
567,100 $29.4 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $1.41 Million - $2.09 Million
-34,160 Reduced 6.14%
522,060 $30.8 Million
Q3 2021

Nov 05, 2021

BUY
$39.25 - $50.42 $21.8 Million - $28 Million
556,220 New
556,220 $23.9 Million
Q1 2021

May 07, 2021

SELL
$33.49 - $37.77 $13.9 Million - $15.7 Million
-415,080 Closed
0 $0
Q4 2020

Feb 01, 2021

SELL
$33.47 - $42.56 $379,549 - $482,630
-11,340 Reduced 2.66%
415,080 $15.3 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $3.86 Million - $4.53 Million
-121,640 Reduced 22.19%
426,420 $15.7 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $563,846 - $684,028
-18,720 Reduced 3.3%
548,060 $17.9 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $5.34 Million - $7.63 Million
197,610 Added 53.53%
566,780 $18.5 Million
Q4 2019

Jan 24, 2020

SELL
$32.92 - $37.36 $498,408 - $565,630
-15,140 Reduced 3.94%
369,170 $14.5 Million
Q3 2019

Oct 21, 2019

SELL
$32.49 - $42.13 $450,961 - $584,764
-13,880 Reduced 3.49%
384,310 $13.8 Million
Q2 2019

Jul 23, 2019

BUY
$36.98 - $41.52 $1.33 Million - $1.49 Million
35,890 Added 9.91%
398,190 $17.2 Million
Q1 2019

Apr 29, 2019

BUY
$37.5 - $41.2 $13.6 Million - $14.9 Million
362,300 New
362,300 $15.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $165B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Nippon Life Global Investors Americas, Inc. Portfolio

Follow Nippon Life Global Investors Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nippon Life Global Investors Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nippon Life Global Investors Americas, Inc. with notifications on news.